Clinical Trial

A Neuro-Technological Intervention for Adolescents With GAD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-01-22; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2020-02-25
Trial Details
NCT Number NCT03813290
Lead Sponsor National Healthcare Group, Singapore
Collaborators: Duke-NUS Graduate Medical School, Singapore General Hospital, Nanyang Technological University
Conditions Generalised Anxiety Disorder
Enrollment 30 participants
Start Date 2020-12-08
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-22